DEBRISOQUINE METABOLISM AND GENETIC PREDISPOSITION TO LUNG-CANCER

被引：73

作者：

LAW, MR

HETZEL, MR

IDLE, JR

机构：

[1] WHITTINGTON HOSP,LONDON N19 5NF,ENGLAND

[2] ST MARYS HOSP,SCH MED,DEPT PHARMACOL & TOXICOL,LONDON W2 1PG,ENGLAND

来源：

BRITISH JOURNAL OF CANCER | 1989年 / 59卷 / 05期

关键词：

D O I：

10.1038/bjc.1989.142

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：686 / 687

页数：2

共 11 条

[1] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].

AYESH, R ;

IDLE, JR ;

RITCHIE, JC ;

CROTHERS, MJ ;

HETZEL, MR .

NATURE, 1984, 312 (5990) :169-170

[2]

EICHELBAUM M, 1984, FED PROC, V43, P2298

[3] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[4] CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].

GONZALEZ, FJ ;

SKODA, RC ;

KIMURA, S ;

UMENO, M ;

ZANGER, UM ;

NEBERT, DW ;

GELBOIN, HV ;

HARDWICK, JP ;

MEYER, UA .

NATURE, 1988, 331 (6155) :442-446

[5] METABOLISM OF [C-14]-DEBRISOQUINE IN MAN [J].

IDLE, JR ;

MAHGOUB, A ;

ANGELO, MM ;

DRING, LG ;

LANCASTER, R ;

SMITH, RL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (03) :257-266

[6]

MILLER JA, 1983, BRIT J CANCER, V48, P115

[7] CLINICAL-PHARMACOLOGY - POSSIBLE CLINICAL IMPORTANCE OF GENETIC-DIFFERENCES IN DRUG-METABOLISM [J].

NEBERT, DW .

BMJ-BRITISH MEDICAL JOURNAL, 1981, 283 (6290) :537-542

[8]

ROOTS I, 1988, KLIN WOCHENSCHR, V66, P87

[9] IMPAIRMENT OF DRUG METABOLISM IN TUMOR-BEARING ANIMALS [J].

ROSSO, R ;

DONELLI, MG ;

FRANCHI, G ;

GARATTINI, S .

EUROPEAN JOURNAL OF CANCER, 1971, 7 (06) :565-+

[10] POLYMORPHISM OF CARBON OXIDATION OF DRUGS AND CLINICAL IMPLICATIONS [J].

SLOAN, TP ;

MAHGOUB, A ;

LANCASTER, R ;

IDLE, JR ;

SMITH, RL .

BRITISH MEDICAL JOURNAL, 1978, 2 (6138) :655-657

← 1 2 →